Natco launches generic version of multiple sclerosis drug in India
New Delhi: Drug firm Natco Pharma said it has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting forms of multiple sclerosis in India.
The company has launched the product under brand name 'Denopsy', Natco Pharma said in a filing to BSE.
"This is the first oral medicine for relapsing and remitting forms of multiple sclerosis being offered in India at two different strengths - 14 mg and 7 mg tablets" it added.
Teriflunomide is sold by Sanofi-Genzyme under the brand name of Aubagio in the US market, Natco Pharma said.
The generic product is priced much lower than other alternate options in India, it added without disclosing the price of the tablets.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd